Advanced Search
MyIDEAS: Login to follow this author

Patricia M. Danzon

Contents:

This is information that was supplied by Patricia Danzon in registering through RePEc. If you are Patricia M. Danzon , you may change this information at the RePEc Author Service. Or if you are not registered and would like to be listed as well, register at the RePEc Author Service. When you register or update your RePEc registration, you may identify the papers and articles you have authored.

Personal Details

First Name: Patricia
Middle Name: M.
Last Name: Danzon
Suffix:

RePEc Short-ID: pda291

Email: [This author has chosen not to make the email address public]
Homepage: http://hc.wharton.upenn.edu/danzon/
Postal Address:
Phone:

Affiliation

Wharton School
University of Pennsylvania
Location: Philadelphia, Pennsylvania (United States)
Homepage: http://www.wharton.upenn.edu/
Email:
Phone: 215.898.4159
Fax: 215.898.1883
Postal: 1030 Steinberg Hall-Dietrich Hall, 3620 Locust Walk, Philadelphia, PA 19104
Handle: RePEc:edi:wsupaus (more details at EDIRC)

Works

as in new window

Working papers

  1. Patricia M. Danzon & Adrian K. Towse & Jorge Mestre-Ferrandiz, 2012. "Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context," NBER Working Papers 18593, National Bureau of Economic Research, Inc.
  2. Patricia M. Danzon & Michael F. Furukawa, 2011. "Cross-National Evidence on Generic Pharmaceuticals: Pharmacy vs. Physician-Driven Markets," NBER Working Papers 17226, National Bureau of Economic Research, Inc.
  3. Patricia M. Danzon & Nuno S. Pereira, 2011. "Vaccine Supply: Effects Of Regulation And Competition," NBER Working Papers 17205, National Bureau of Economic Research, Inc.
  4. Patricia M. Danzon & Andrew W. Mulcahy & Adrian K. Towse, 2011. "Pharmaceutical Pricing in Emerging Markets: Effects of Income, Competition and Procurement," NBER Working Papers 17174, National Bureau of Economic Research, Inc.
  5. Patricia M. Danzon & Andrew J. Epstein, 2008. "Effects of Regulation on Drug Launch and Pricing in Interdependent Markets," NBER Working Papers 14041, National Bureau of Economic Research, Inc.
  6. Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2004. "Mergers and Acquisitions in the Pharmaceutical and Biotech Industries," NBER Working Papers 10536, National Bureau of Economic Research, Inc.
  7. Patricia M. Danzon & Sean Nicholson & Nuno Sousa Pereira, 2003. "Productivity in Pharmaceutical Biotechnology R&D: The Role of Experience and Alliances," NBER Working Papers 9615, National Bureau of Economic Research, Inc.
  8. Patricia M. Danzon & Y. Richard Wang & Liang Wang, 2003. "The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from Twenty-Five Major Markets in the 1990s," NBER Working Papers 9874, National Bureau of Economic Research, Inc.
  9. Patricia M. Danzon & Jonathan D. Ketcham, 2003. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands and New Zealand," NBER Working Papers 10007, National Bureau of Economic Research, Inc.
  10. Patricia M. Danzon & Stephen B. Soumerai, 2002. "Pharmaceuticals: Access, Cost, Pricing, and Directions for the Future. 13th Annual Herbert Lourie Memorial Lecture on Health Policy," Center for Policy Research Policy Briefs, Center for Policy Research, Maxwell School, Syracuse University 23, Center for Policy Research, Maxwell School, Syracuse University.
  11. Sean Nicholson & Patricia M. Danzon & Jeffrey S. McCullough, 2002. "Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality," NBER Working Papers 9007, National Bureau of Economic Research, Inc.
  12. Patricia M. Danzon, 1990. "Mandated Employment-Based Health Insurance:Incidence and Efficiency Effects," University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State 60, Chicago - Center for Study of Economy and State.
  13. Pauly Danzon. Patricia M. & Kington Mark V. & Raynard S., 1990. "The Effects of Malpractice Litigation on Physicians' Fees and Incomes," University of Chicago - George G. Stigler Center for Study of Economy and State, Chicago - Center for Study of Economy and State 59, Chicago - Center for Study of Economy and State.

    RePEc:reg:wpaper:258 is not listed on IDEAS

Articles

  1. Patricia Danzon & Nuno Sousa Pereira, 2011. "Vaccine Supply: Effects of Regulation and Competition," International Journal of the Economics of Business, Taylor & Francis Journals, Taylor & Francis Journals, vol. 18(2), pages 239-271.
  2. Harrington, Scott E. & Danzon, Patricia M. & Epstein, Andrew J., 2008. ""Crises" in medical malpractice insurance: Evidence of excessive price-cutting in the preceding soft market," Journal of Banking & Finance, Elsevier, Elsevier, vol. 32(1), pages 157-169, January.
  3. Ernst R. Berndt & Patricia M. Danzon & Gregory B. Kruse, 2007. "Dynamic competition in pharmaceuticals: cross-national evidence from new drug diffusion," Managerial and Decision Economics, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 28(4-5), pages 231-250.
  4. Patricia M. Danzon & Andrew Epstein & Sean Nicholson, 2007. "Mergers and acquisitions in the pharmaceutical and biotech industries," Managerial and Decision Economics, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 28(4-5), pages 307-328.
  5. Danzon, Patricia M. & Nicholson, Sean & Pereira, Nuno Sousa, 2005. "Productivity in pharmaceutical-biotechnology R&D: the role of experience and alliances," Journal of Health Economics, Elsevier, Elsevier, vol. 24(2), pages 317-339, March.
  6. Patricia M. Danzon & Y. Richard Wang & Liang Wang, 2005. "The impact of price regulation on the launch delay of new drugs-evidence from twenty-five major markets in the 1990s," Health Economics, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 14(3), pages 269-292.
  7. Danzon Patricia M. & Ketcham Jonathan D., 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," Forum for Health Economics & Policy, De Gruyter, De Gruyter, vol. 7(1), pages 1-56, January.
  8. Mark V. Pauly & Sean Nicholson & Judy Xu & Dan Polsky & Patricia M. Danzon & James F. Murray & Marc L. Berger, 2002. "A general model of the impact of absenteeism on employers and employees," Health Economics, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 11(3), pages 221-231.
  9. Danzon, Patricia M., 2002. "Welfare effects of supplementary insurance: a comment," Journal of Health Economics, Elsevier, Elsevier, vol. 21(5), pages 923-926, September.
  10. Danzon, Patricia M & Harrington, Scott E, 2001. "Worker's Compensation Rate Regulation: How Price Controls Increase Costs," Journal of Law and Economics, University of Chicago Press, University of Chicago Press, vol. 44(1), pages 1-36, April.
  11. Danzon, Patricia & Sloan, Frank, 2001. "Comments on "The Assault on Managed Care: Vicarious Liability, ERISA Preemption, and Class Actions."," The Journal of Legal Studies, University of Chicago Press, University of Chicago Press, vol. 30(2), pages 661-68, June.
  12. Danzon, Patricia M. & Chao, Li-Wei, 2000. "Cross-national price differences for pharmaceuticals: how large, and why?," Journal of Health Economics, Elsevier, Elsevier, vol. 19(2), pages 159-195, March.
  13. Danzon, Patricia M & Chao, Li-Wei, 2000. "Does Regulation Drive out Competition in Pharmaceutical Markets?," Journal of Law and Economics, University of Chicago Press, University of Chicago Press, vol. 43(2), pages 311-57, October.
  14. Harrington, Scott E & Danzon, Patricia M, 2000. "Rate Regulation, Safety Incentives, and Loss Growth in Workers' Compensation Insurance," The Journal of Business, University of Chicago Press, University of Chicago Press, vol. 73(4), pages 569-95, October.
  15. Adrian Towse & Patricia Danzon, 1999. "Medical negligence and the NHS: an economic analysis," Health Economics, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 8(2), pages 93-101.
  16. Patricia Danzon & Adrian Towse, 1998. "`The Pros and Cons of a Single Euro-Price for Drugs' and `The Economics of Parallel Trade'," PharmacoEconomics, Springer Healthcare | Adis, Springer Healthcare | Adis, vol. 14(1), pages 135-137.
  17. Patricia M. Danzon, 1998. "The Economics of Parallel Trade," PharmacoEconomics, Springer Healthcare | Adis, Springer Healthcare | Adis, vol. 13(3), pages 293-304.
  18. Patricia Danzon, 1997. "Price Discrimination for Pharmaceuticals: Welfare Effects in the US and the EU," International Journal of the Economics of Business, Taylor & Francis Journals, Taylor & Francis Journals, vol. 4(3), pages 301-322.
  19. Cummins, J. David & Danzon, Patricia M., 1997. "Price, Financial Quality, and Capital Flows in Insurance Markets," Journal of Financial Intermediation, Elsevier, Elsevier, vol. 6(1), pages 3-38, January.
  20. Danzon, Patricia M, 1997. "Tort Liability: A Minefield for Managed Care?," The Journal of Legal Studies, University of Chicago Press, University of Chicago Press, vol. 26(2), pages 491-519, June.
  21. Patricia M. Danzon, 1995. "A measure of malpractice: Medical injury, malpractice litigation and patient compensation, by Paul C. Weiler et al. Cambridge, MA: Harvard University Press, 1993, 178 pp., $29.95 cloth," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 14(4), pages 636-638.
  22. Danzon, Patricia M, 1994. "Tort Reform: The Case of Medical Malpractice," Oxford Review of Economic Policy, Oxford University Press, Oxford University Press, vol. 10(1), pages 84-98, Spring.
  23. Danzon, Patrigia M., 1994. "The Swedish patient compensation system: Myths and realities," International Review of Law and Economics, Elsevier, Elsevier, vol. 14(4), pages 453-466, December.
  24. Patricia M. Danzon & Grant D. H. Maclaine, 1994. "Health Care Reform," Australian Economic Review, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, The University of Melbourne, Melbourne Institute of Applied Economic and Social Research, vol. 27(2), pages 81-88.
  25. Harrington, Scott E & Danzon, Patricia M, 1994. "Price Cutting in Liability Insurance Markets," The Journal of Business, University of Chicago Press, University of Chicago Press, vol. 67(4), pages 511-38, October.
  26. Danzon, Patricia M, 1993. "The Economic Implications of Public Disability Insurance in the United States," Journal of Labor Economics, University of Chicago Press, University of Chicago Press, vol. 11(1), pages S170-200, January.
  27. Danzon, Patricia, 1993. "Holdouts, Externalities, and the Single Owner: One More Salute to Ronald Coase: Comment," Journal of Law and Economics, University of Chicago Press, University of Chicago Press, vol. 36(1), pages 587-94, April.
  28. Patricia M. Danzon, 1991. "Liability for Medical Malpractice," Journal of Economic Perspectives, American Economic Association, American Economic Association, vol. 5(3), pages 51-69, Summer.
  29. Danzon, Patricia M & Pauly, Mark V & Kington, Raynard S, 1990. "The Effects of Malpractice Litigation on Physicians' Fees and Incomes," American Economic Review, American Economic Association, American Economic Association, vol. 80(2), pages 122-27, May.
  30. Patricia M Danzon, 1990. "Alternative Liability Regimes for Medical Injuries," The Geneva Papers on Risk and Insurance - Issues and Practice, Palgrave Macmillan, Palgrave Macmillan, vol. 15(1), pages 3-21, January.
  31. Danzon, Patricia M, 1988. "The Political Economy of Workers' Compensation: Lessons for Product Liability," American Economic Review, American Economic Association, American Economic Association, vol. 78(2), pages 305-10, May.
  32. Danzon, Patricia M., 1985. "Liability and liability insurance for medical malpractice," Journal of Health Economics, Elsevier, Elsevier, vol. 4(4), pages 309-331, December.
  33. Danzon, Patricia, 1984. "The Frequency and Severity of Medical Malpractice Claims," Journal of Law and Economics, University of Chicago Press, University of Chicago Press, vol. 27(1), pages 115-48, April.
  34. Flowers, Marilyn R. & Danzon, Patricia M., 1984. "Separation of the redistributive and allocative functions of government : A public choice perspective," Journal of Public Economics, Elsevier, Elsevier, vol. 24(3), pages 373-380, August.
  35. Patricia Munch Danzon, 1983. "Regulatory policy and practices: Regulating better and regulating less, by Fred Thomson and L.R. Jones. New York: Praeger Publishers, 1982, 253 pp. Price: $29.95," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 3(1), pages 154-154.
  36. Patricia Munch Danzon, 1983. "Contingent Fees for Personal Injury Litigation," Bell Journal of Economics, The RAND Corporation, The RAND Corporation, vol. 14(1), pages 213-224, Spring.
  37. Patricia Munch Danzon, 1983. "Risk by choice: Regulating health and safety in the workplace, by W. Kip Viscusi. Cambridge, MA: Harvard University Press, 1983, 200 pp. Price: $18.50," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 3(1), pages 154-155.
  38. Patricia Munch Danzon, 1982. "Regulation and its reform, by Stephen Breyer. Cambridge, MA: Harvard University Press, 1982, 472 pp. Price: $25.00," Journal of Policy Analysis and Management, John Wiley & Sons, Ltd., John Wiley & Sons, Ltd., vol. 2(1), pages 141-141.
  39. Danzon, Patricia Munch, 1982. "Hospital `profits' : The effects of reimbursement policies," Journal of Health Economics, Elsevier, Elsevier, vol. 1(1), pages 29-52, May.

Chapters

  1. Patricia M. Danzon & Eric L. Keuffel, 2013. "Regulation of the Pharmaceutical-Biotechnology Industry," NBER Chapters, National Bureau of Economic Research, Inc, in: Economic Regulation and Its Reform: What Have We Learned?, pages 407-484 National Bureau of Economic Research, Inc.
  2. Patricia M. Danzon & Jonathan D. Ketcham, 2004. "Reference Pricing of Pharmaceuticals for Medicare: Evidence from Germany, the Netherlands, and New Zealand," NBER Chapters, National Bureau of Economic Research, Inc, in: Frontiers in Health Policy Research, Volume 7, pages 1-54 National Bureau of Economic Research, Inc.
  3. Danzon, Patricia M., 2000. "Liability for medical malpractice," Handbook of Health Economics, Elsevier, in: A. J. Culyer & J. P. Newhouse (ed.), Handbook of Health Economics, edition 1, volume 1, chapter 26, pages 1339-1404 Elsevier.
  4. Patricia M. Danzon & Allison Percy, 1999. "The Effects of Price Regulation on Productivity in Pharmaceuticals," NBER Chapters, National Bureau of Economic Research, Inc, in: International and Interarea Comparisons of Income, Output, and Prices, pages 371-418 National Bureau of Economic Research, Inc.

Books

  1. Danzon, Patricia M. & Nicholson, Sean (ed.), 2012. "The Oxford Handbook of the Economics of the Biopharmaceutical Industry," OUP Catalogue, Oxford University Press, Oxford University Press, number 9780199742998, October.

NEP Fields

9 papers by this author were announced in NEP, and specifically in the following field reports (number of papers):
  1. NEP-ACC: Accounting & Auditing (1) 2004-06-07
  2. NEP-BEC: Business Economics (1) 2011-07-27
  3. NEP-CFN: Corporate Finance (1) 2004-06-07
  4. NEP-COM: Industrial Competition (6) 2003-11-30 2004-06-07 2008-06-07 2011-07-13 2011-07-27 2012-12-15. Author is listed
  5. NEP-EDU: Education (2) 2003-07-29 2003-11-30
  6. NEP-EEC: European Economics (1) 2003-11-30
  7. NEP-ENT: Entrepreneurship (1) 2003-04-13
  8. NEP-HEA: Health Economics (6) 2003-04-13 2003-07-29 2004-06-07 2008-06-07 2011-07-13 2011-07-27. Author is listed
  9. NEP-HME: Heterodox Microeconomics (2) 2011-07-13 2011-07-27
  10. NEP-IND: Industrial Organization (1) 2003-04-13
  11. NEP-LAW: Law & Economics (1) 2008-06-07
  12. NEP-MIC: Microeconomics (1) 2008-06-07
  13. NEP-MKT: Marketing (1) 2008-06-07
  14. NEP-REG: Regulation (2) 2008-06-07 2011-07-27

Statistics

This author is among the top 5% authors according to these criteria:
  1. Number of Distinct Works, Weighted by Simple Impact Factor
  2. Number of Distinct Works, Weighted by Recursive Impact Factor
  3. Number of Distinct Works, Weighted by Number of Authors and Simple Impact Factors
  4. Number of Distinct Works, Weighted by Number of Authors and Recursive Impact Factors
  5. Number of Citations, Weighted by Number of Authors
  6. h-index
  7. Number of Journal Pages
  8. Number of Journal Pages, Weighted by Simple Impact Factor
  9. Number of Journal Pages, Weighted by Number of Authors
  10. Number of Journal Pages, Weighted by Number of Authors and Simple Impact Factors
  11. Number of Journal Pages, Weighted by Number of Authors and Recursive Impact Factors
  12. Number of Abstract Views in RePEc Services over the past 12 months, Weighted by Number of Authors

Most cited item

Most downloaded item (past 12 months)

Access and download statistics for all items

Co-authorship network on CollEc

Corrections

For general information on how to correct material on RePEc, see these instructions.

To update listings or check citations waiting for approval, Patricia Danzon should log into the RePEc Author Service

To make corrections to the bibliographic information of a particular item, find the technical contact on the abstract page of that item. There, details are also given on how to add or correct references and citations.

To link different versions of the same work, where versions have a different title, use this form. Note that if the versions have a very similar title and are in the author's profile, the links will usually be created automatically.

Please note that most corrections can take a couple of weeks to filter through the various RePEc services.